Comparison of the Efficacy of Denosumab and Alendronate in Improving Bone Mineral Density in Osteoporosis Patients and High-Risk Populations: A Systematic Review and Meta-Analysis | Synapse
March 3, 2026
Comparison of the Efficacy of Denosumab and Alendronate in Improving Bone Mineral Density in Osteoporosis Patients and High-Risk Populations: A Systematic Review and Meta-Analysis
Key Points
Denosumab shows a greater improvement in bone mineral density compared to alendronate.
The review included studies involving various populations at high risk for osteoporosis-related fractures.
Meta-analysis conducted across multiple studies provides comprehensive data on treatment effects.
This analysis highlights the need for further research to confirm long-term outcomes associated with both medications.